204 related articles for article (PubMed ID: 11806858)
21. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).
Price LH; Malison RT; McDougle CJ; McCance-Katz EF; Owen KR; Heninger GR
Neuropsychopharmacology; 1997 Nov; 17(5):342-50. PubMed ID: 9348549
[TBL] [Abstract][Full Text] [Related]
22. Mood-independent aberrancies in associative processes in bipolar affective disorder: an apparent stabilizing effect of lithium.
Pons L; Nurnberger JI; Murphy DL
Psychiatry Res; 1985 Apr; 14(4):315-22. PubMed ID: 3860884
[TBL] [Abstract][Full Text] [Related]
23. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
[TBL] [Abstract][Full Text] [Related]
24. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.
Benkelfat C; Ellenbogen MA; Dean P; Palmour RM; Young SN
Arch Gen Psychiatry; 1994 Sep; 51(9):687-97. PubMed ID: 8080345
[TBL] [Abstract][Full Text] [Related]
25. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.
Haynes PL; McQuaid JR; Kelsoe J; Rapaport M; Gillin JC
J Affect Disord; 2004 Dec; 83(2-3):253-62. PubMed ID: 15555723
[TBL] [Abstract][Full Text] [Related]
26. Valproate for acute mood episodes in bipolar disorder.
Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
[TBL] [Abstract][Full Text] [Related]
27. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.
Kallner G; Lindelius R; Petterson U; Stockman O; Tham A
Pharmacopsychiatry; 2000 Jan; 33(1):8-13. PubMed ID: 10721878
[TBL] [Abstract][Full Text] [Related]
28. Serotonergic function during lithium augmentation of refractory depression.
McCance-Katz E; Price LH; Charney DS; Heninger GR
Psychopharmacology (Berl); 1992; 108(1-2):93-7. PubMed ID: 1410150
[TBL] [Abstract][Full Text] [Related]
29. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
30. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
31. Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder.
Quintin P; Benkelfat C; Launay JM; Arnulf I; Pointereau-Bellenger A; Barbault S; Alvarez JC; Varoquaux O; Perez-Diaz F; Jouvent R; Leboyer M
Biol Psychiatry; 2001 Aug; 50(3):184-90. PubMed ID: 11513817
[TBL] [Abstract][Full Text] [Related]
32. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
[TBL] [Abstract][Full Text] [Related]
33. Multicompartmental analysis of amino acid. 1. Preliminary data on concentrations, fluxes, and flow constants of tryptophan in affective illness.
Shaw DM; Johnson AL; Tidmarsh ; Macsweeney DA; Hewland HR; Woolcock NE
Psychol Med; 1975 May; 5(2):206-13. PubMed ID: 1161958
[TBL] [Abstract][Full Text] [Related]
34. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy.
Neumeister A; Turner EH; Matthews JR; Postolache TT; Barnett RL; Rauh M; Vetticad RG; Kasper S; Rosenthal NE
Arch Gen Psychiatry; 1998 Jun; 55(6):524-30. PubMed ID: 9633671
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of lithium in the prophylaxis of affective disorders].
Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
[TBL] [Abstract][Full Text] [Related]
37. [Mood stabilizers--past, present and future].
Sümegi A
Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
[TBL] [Abstract][Full Text] [Related]
38. Prediction of lithium response using. m-chlorophenylpiperazine challenge test: A preliminary finding.
Terao T; Nakamura J; Yoshimura R; Ohmori O; Takahashi N; Shinkai T
Int Clin Psychopharmacol; 2000 Jan; 15(1):39-42. PubMed ID: 10836285
[TBL] [Abstract][Full Text] [Related]
39. The effects of tryptophan depletion on mood and psychiatric symptoms.
Van der Does AJ
J Affect Disord; 2001 May; 64(2-3):107-19. PubMed ID: 11313078
[TBL] [Abstract][Full Text] [Related]
40. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
